WallStreetZenWallStreetZen

NASDAQ: TGTX
Tg Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Tg Therapeutics earnings were $441.5M for the trailing 12 months ending Jun 30, 2026, with 651.2% growth year over year. The latest TGTX earnings report on Jun 30, 2026 announced Q2 2026 earnings of $7.8M, down 60.7% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, TGTX reported annual earnings of $447.2M, with 1,812.4% growth.

TGTX past earnings growth

How has TGTX's earnings growth performed historically?

Company
651.22%
Industry
17.3%
Market
92%
TGTX's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
TGTX's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance
TGTX's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

TGTX earnings history

Current Revenue
$799.5M
Current Earnings
$441.5M
Current Profit Margin
55.2%

TGTX Return on Equity

Current Company
72.3%
Current Industry
-13.6%
Current Market
33.3%
TGTX's Return on Equity (72.3%)... subscribe to Premium to read more.
High Return on Equity Performance

TGTX Return on Assets

Current Company
33.6%
Current Industry
-10.2%
TGTX is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when TGTX announces earnings.

TGTX Return on Capital Employed

Current Company
10.14%
Current Industry
-6.7%
TGTX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TGTX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
TGTX$139.21M$441.49M+112.82%$3.08
IMVT-$538.42M-$538.22MN/A-$2.82
IBRX-$854.88M-$992.36MN/A-$0.97
SYRE-$178.92M-$178.92MN/A-$1.99
PCVX-$1.04B-$1.06BN/A-$7.63
View Top Biotech Stocks

Tg Therapeutics Earnings Reports & History FAQ

What were Tg Therapeutics's earnings last quarter?

On TGTX's earnings call on Aug 3, 2026, Tg Therapeutics (NASDAQ: TGTX) reported Q2 2026 earnings per share (EPS) of $0.05, up 73.68% year over year. Total TGTX earnings for the quarter were $7.78 million. In the same quarter last year, Tg Therapeutics's earnings per share (EPS) was $0.19.

If you're new to stock investing, here's how to buy Tg Therapeutics stock.

Is Tg Therapeutics profitable or losing money?

As of the last Tg Therapeutics earnings report, Tg Therapeutics is currently profitable. Tg Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2026 was $441.49 million, a 630.24% increase year over year.

What was TGTX's earnings growth in the past year?

As of Tg Therapeutics's earnings date in Aug 3, 2026, Tg Therapeutics's earnings has grown 651.22% year over year. This is 633.92 percentage points higher than the US Biotechnology industry earnings growth rate of 17.3%. TGTX earnings in the past year totalled $441.49 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.